| Gene: | CD3G |
| GeneID: | ENSG00000160654 |
| Chrom: | 11 |
| Start position: | 118344344 |
| End position: | 118355161 |
| Pathway: | Hematopoietic cell lineage |
| Class: | Organismal Systems; Immune system |
| FST gene level: | 0.121831 |
| Number of nsSNPs: | 1 |
| nsSNPs in gene: | rs3753058 |
| Gene Structure: |  |
| |
Overall distribution
|
|
Tissue specific distribution
|
| |
|
|
| Expression restricted in 1 cancer type(s) | |
|
| |
|
|
|
| |
Overall distribution
|
|
Tissue specific distribution
|
| |
| Gscore (Amp): | 0.00 | | Gscore (Del): | 0.23 |
|
|
|
| Recurrently deleted in 1 cancer type(s) |
|
| |
|
|
|
| |
Overall distribution
|
|
Tissue specific distribution
|
| |
|
|
|
| |
|
|
|
| Functional class: | Not specified |
| JensenLab PubMed score: | 223.52 (Percentile rank: 82.99%) |
| PubTator score: | 107.30 (Percentile rank: 78.66%) |
| Target development/druggability level: | TclinThese targets have activities in DrugCentral (ie. approved drugs) with known mechanism of action. |
| Tractability (small molecule): | N/A |
| Tractability (antibody): | Clinical PrecedenceTargets with drugs in phase II or above; Pre-clinical targets |
